跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
Tsung Hsien Chiang
, Masahiro Maeda
, Harumi Yamada
, Chang Chuan Chan
, Sam Li Sheng Chen
, Sherry Yueh Hsia Chiu
, Yen Nien Chen
, Yi Hsuan Chou
, Chun Fu Shieh
, Cheng Ying Liu
, Han Mo Chiu
, Hung Chiang
, Chia Tung Shun
,
Ming Wei Lin
, Ming Shiang Wu
, Jaw Town Lin
, Hsiu Hsi Chen
, Toshikazu Ushijima
, David Y. Graham
, Yi Chia Lee
*
*
此作品的通信作者
公共衛生研究所
研究成果
:
Article
›
同行評審
23
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Risk Stratification
100%
Population-based Study
100%
Gastric Cancer
100%
Helicobacter Pylori Eradication
100%
Pepsinogen
100%
Matsu Islands
100%
Gastrin-17 (G-17)
80%
Genetic Damage
60%
Index Lesion
60%
Premalignant Lesions
40%
Helicobacter Pylori (H. pylori)
40%
Serological Test
40%
Methylation Status
40%
Mucosa
40%
Positive Likelihood Ratio
40%
Pepsinogen Test
40%
Negative Likelihood Ratio
40%
High-risk Population
20%
Screening Program
20%
Confidence Interval
20%
Histology
20%
Stomach
20%
Risky Driving
20%
False-negative Results
20%
DNA Methylation (DNAm)
20%
Gastritis
20%
Endoscopic Diagnosis
20%
Atrophic Gastritis
20%
Gastric Cancer Risk
20%
MiR-124
20%
Immunoglobin G
20%
Post-eradication
20%
Direct Testing
20%
Medicine and Dentistry
Risk Stratification
100%
Helicobacter Pylori
100%
Pepsinogen
100%
Abdominal Cancer
100%
Gastrin 17
80%
Genetic Damage
60%
Serological Test
40%
Mucosa
40%
microRNA
20%
Screening
20%
Methylation
20%
DNA Methylation
20%
High Risk Population
20%
Cancer Risk
20%
Immunoglobulin
20%
Gastritis
20%
Atrophic Gastritis
20%
False Negative Result
20%
Pepsinogen II
20%
Pepsinogen I
20%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
100%
Pepsinogen
100%
Abdominal Cancer
100%
Gastrin 17
80%
microRNA
20%
Immunoglobulin
20%
Gastritis
20%
Atrophic Gastritis
20%
Pepsinogen I
20%
Pepsinogen II
20%